TM9SF2

Transmembrane 9 superfamily member 2 · Q99805 · TM9SF2 on Sugi Atlas →

0 patent compounds predicted against TM9SF2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TM9SF2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma PHASE2RECRUITING
Lovaza's Effect on the Activation of Platelets PHASE2COMPLETED
Pembrolizumab (MK-3475) in MM Patients With Residual Disease PHASE2COMPLETED
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma PHASE2UNKNOWN
ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy PHASE2COMPLETED
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis EARLY_PHASE1RECRUITING
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis EARLY_PHASE1UNKNOWN
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA nanRECRUITING
Evaluation of Risk of hEpatocellular Carcinoma nanRECRUITING
Lifestyle Intervention in Fatty Liver (NAFLD) nanUNKNOWN
In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects nanUNKNOWN
Clinical Research on 68Ga-FAPI PET/CMR in Cardiovascular Diseases nanRECRUITING
Study of Constitutional Platelet Disease nanUNKNOWN
A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1- and EpCAM-positive Solid Tumors nanUNKNOWN
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. nanUNKNOWN
Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern Benin nanCOMPLETED
Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism nanUNKNOWN
Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors nanNOT_YET_RECRUITING
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus nanCOMPLETED
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
Correlation Between Serum Markers of Unstable Plaque and Virtual Histology of Unstable Plaque Visualized by IVUS nanCOMPLETED
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Molecular & Clinical Evaluation of Low HDL Syndromes nanCOMPLETED
Genetic Study of Age-Related Macular Degeneration nanCOMPLETED
Uterine Cavity Assessment and Endometrial Gene Expression in Tamoxifen Treated Breast Cancer Patients nanUNKNOWN
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a TM9SF2 binder may also engage these)

ProteinNameSimilarity
Q66HG5 1.000 Q66HG5 →
P58021 1.000 P58021 →
Q5R8Y6 1.000 Q5R8Y6 →
A5D7E2 1.000 A5D7E2 →
Q8BH24 1.000 Q8BH24 →
Q9ET30 1.000 Q9ET30 →
F4KIB2 1.000 F4KIB2 →
TM9SF3 Transmembrane 9 superfamily member 3 1.000 landscape →
Q8RWW1 1.000 Q8RWW1 →
Q9LIC2 1.000 Q9LIC2 →
Q9FYQ8 1.000 Q9FYQ8 →
Q9C720 0.999 Q9C720 →
Q5RDY2 0.998 Q5RDY2 →
TM9SF4 Transmembrane 9 superfamily member 4 0.998 landscape →
Q4KLL4 0.996 Q4KLL4 →
Q940G0 0.996 Q940G0 →
F4JRE0 0.996 F4JRE0 →
Q9C5N2 0.996 Q9C5N2 →
O15321 0.996 O15321 →
Q5R8F1 0.995 Q5R8F1 →
Q04562 0.995 Q04562 →
Q55FP0 0.994 Q55FP0 →
A4IFE9 0.993 A4IFE9 →
F4HW17 0.992 F4HW17 →
Q66HF2 0.992 Q66HF2 →
Q9Y819 0.991 Q9Y819 →
P32802 0.989 P32802 →
A9UY97 0.988 A9UY97 →
O80580 0.988 O80580 →
O22815 0.988 O22815 →